首页 > 最新文献

Journal of Diabetes and Metabolic Disorders最新文献

英文 中文
Relationship of cardiovascular risk factors, pericardial fat, and carotid thickness with coronary plaque type in patients with diabetes mellitus. 糖尿病患者心血管危险因素、心包脂肪和颈动脉厚度与冠状动脉斑块类型的关系。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-02-13 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01190-9
Hussein Nafakhi, Hayder Qassim Elwali, Kareem M Khalaf Al-Sharea, Abdulameer A Al-Mosawi

Background: There is paucity of data on the potential predictors of coronary plaque types among patients with diabetes mellitus(DM).

Aims: To assess the association of cardiovascular risk factors, pericardial fat volume (PFV) assessed by multi-detector CT(MDCT)angiography, and internal carotid intima media thickness with coronary atherosclerotic plaque types in patients with type 2 DM.

Patients and methods: Patients with suspected coronary artery disease who underwent 64-slice MDCT angiography were enrolled in this retrospective study.

Results: A total of 784 patients were enrolled in this study, 198 of whom had DM and 586 of whom did not. The prevalence of calcified and mixed plaques was significantly higher in the DM group than without DM group, while no significant difference was found in the distribution of non-calcified plaque between groups. There was significant association between smoking [OR(CI) = 4(2-10),P = 0.001] and increased age[OR(CI) = 1.1(1-1.3),P = 0.023] and calcified plaque presence. Regarding mixed and non-calcified plaque, increased PFV[OR(CI) = 1.1(1-1.3),P = 0.001] and positive family history[OR(CI) = 4(2-12),P = 0.049] showed a significant association with coronary mixed plaque presence while no significant association was observed between cardiovascular risk factors, PFV, and internal carotid intima media thickness and non-calcified plaque presence in patients with DM.

Conclusion: Increased PFV showed significant and independent association with mixed coronary plaques development, which suggests that PFV may be used as an imaging marker for early detection of increased risk for future coronary events in patients with DM.

背景:关于糖尿病(DM)患者冠状动脉斑块类型的潜在预测因素的数据很少。目的:评估心血管危险因素、多探测器CT(MDCT)血管造影术评估的心包脂肪体积(PFV)、,2型糖尿病患者的颈内动脉内膜-中膜厚度与冠状动脉粥样硬化斑块类型。患者和方法:本回顾性研究纳入了接受64层MDCT血管造影术的疑似冠状动脉疾病患者。结果:共有784名患者参与了这项研究,其中198人患有糖尿病,586人没有。糖尿病组钙化斑块和混合斑块的发生率显著高于无糖尿病组,而非钙化斑块在各组之间的分布没有显著差异。吸烟[OR(CI) = 4(2-10),P = 0.001]和年龄增加[OR(CI) = 1.1(1-1.3),P = 0.023]和钙化斑块的存在。关于混合和非钙化斑块,PFV增加[OR(CI) = 1.1(1-1.3),P = 0.001]和阳性家族史[OR(CI) = 4(2-12),P = 0.049]显示与冠状动脉混合斑块的存在显著相关,而糖尿病患者的心血管危险因素、PFV、颈内动脉内膜-中膜厚度和非钙化斑块的存在之间没有观察到显著关联,这表明PFV可作为早期检测DM患者未来冠状动脉事件风险增加的成像标志物。
{"title":"Relationship of cardiovascular risk factors, pericardial fat, and carotid thickness with coronary plaque type in patients with diabetes mellitus.","authors":"Hussein Nafakhi, Hayder Qassim Elwali, Kareem M Khalaf Al-Sharea, Abdulameer A Al-Mosawi","doi":"10.1007/s40200-023-01190-9","DOIUrl":"10.1007/s40200-023-01190-9","url":null,"abstract":"<p><strong>Background: </strong>There is paucity of data on the potential predictors of coronary plaque types among patients with diabetes mellitus(DM).</p><p><strong>Aims: </strong>To assess the association of cardiovascular risk factors, pericardial fat volume (PFV) assessed by multi-detector CT(MDCT)angiography, and internal carotid intima media thickness with coronary atherosclerotic plaque types in patients with type 2 DM.</p><p><strong>Patients and methods: </strong>Patients with suspected coronary artery disease who underwent 64-slice MDCT angiography were enrolled in this retrospective study.</p><p><strong>Results: </strong>A total of 784 patients were enrolled in this study, 198 of whom had DM and 586 of whom did not. The prevalence of calcified and mixed plaques was significantly higher in the DM group than without DM group, while no significant difference was found in the distribution of non-calcified plaque between groups. There was significant association between smoking [OR(CI) = 4(2-10),P = 0.001] and increased age[OR(CI) = 1.1(1-1.3),P = 0.023] and calcified plaque presence. Regarding mixed and non-calcified plaque, increased PFV[OR(CI) = 1.1(1-1.3),P = 0.001] and positive family history[OR(CI) = 4(2-12),P = 0.049] showed a significant association with coronary mixed plaque presence while no significant association was observed between cardiovascular risk factors, PFV, and internal carotid intima media thickness and non-calcified plaque presence in patients with DM.</p><p><strong>Conclusion: </strong>Increased PFV showed significant and independent association with mixed coronary plaques development, which suggests that PFV may be used as an imaging marker for early detection of increased risk for future coronary events in patients with DM.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"713-719"},"PeriodicalIF":2.8,"publicationDate":"2023-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9556828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of essential metals on insulin sensitivity and fetuin in obesity-related type 2 diabetes pathogenesis. 在肥胖相关的2型糖尿病发病机制中,必需金属对胰岛素敏感性和胎球蛋白的影响。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-02-08 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01193-6
Anumesh K Pathak, Vandana Tiwari, Manish Raj Kulshrestha, Shivani Singh, Shefali Singh, Vikram Singh

Purpose: Essential metals may be crucial in obesity and type 2 diabetes (T2DM); diabesity pathogenesis and consequences. This study aimed to determine the metal levels in obese and non-obese patients with and without T2DM and their relationships with fetuin-A(Fet-A) levels, insulin sensitivity, and insulin resistance.

Methods: A total of 314 participants were enrolled, with 160 newly diagnosed T2DM patients and 154 non-T2DM subjects categorized into diabetic obese (n = 57), diabetic non-obese (n = 103), non-diabetic obese (n = 48), and non-diabetic non-obese (n = 106) subgroups. Fet-A, insulin sensitivity (QUCKI)/resistance (HOMA-IR), fasting glucose, and body mass index (BMI) were assessed. The essential metals were measured using inductively coupled plasma mass spectroscopy (ICP-MS).

Results: Fet-A levels were 3-fold higher (1391.4 ± 839.8 ng/ml) in T2DM patients than in non-T2DM (2165.6 ± 651.9 vs. 424.3 ± 219.1 ng/ml, p < 0.0001). Fet-A levels were 2.3-fold higher in the diabetic obese group than in the diabetic non-obese group (p < 0.0001). Fet-A levels were 2.0-fold higher in the diabetic non-obese group than in the non-diabetic obese group (p < 0.0001). Fet-A levels were positively correlated with insulin resistance (HOMA-IR) (r = 0.34, p < 0.0001) and negatively correlated with insulin sensitivity (QUIKI) (r = -0.41, p < 0.0001).Cu, Se, Zn, and Fe levels were significantly lower in diabetic patients than in non-diabetic patients (p < 0.05). Se and Zn were significantly correlated with Fet-A (r = -0.41, p = 0.049 and r = -0.42, p = 0.001, respectively). Se and Zn were also correlated with insulin resistance (HOMA-IR) (r = -0.45, p = 0.049 and r = -0.36, p = 0.012, respectively) and insulin sensitivity (QUIKI) (r = 0.49, p = 0.042 and r = 0.30, p = 0.003, respectively). Similarly, Fe was negatively correlated with insulin levels (r = -0.33, p = 0.04) and insulin sensitivity (r = -0.34, p = 0.30). However, Mn was significantly correlated with Fet-A (r = 0.37, p = 0.001) and insulin resistance/sensitivity (r = 0.24, p = 0.026 and r = -0.24, p = 0.041) respectively in the diabetic obese group. Mg was an independent predictor of diabesity.

Conclusions: Mg play a significant role in obesity-related T2DM pathogenesis and complications via Fet-A, insulin sensitivity, and resistance modifications.

目的:必需金属可能在肥胖和2型糖尿病(T2DM)中起关键作用;糖尿病的发病机制和后果。本研究旨在确定患有和不患有T2DM的肥胖和非肥胖患者的金属水平及其与胎球蛋白-A(Fet-A)水平、胰岛素敏感性和胰岛素抵抗的关系。方法:共有314名参与者被纳入研究,其中160名新诊断的T2DM患者和154名非T2DM受试者被归类为糖尿病性肥胖(n = 57)、糖尿病非肥胖(n = 103)、非糖尿病性肥胖(n = 48)和非糖尿病非肥胖(n = 106)亚组。评估胎儿A、胰岛素敏感性(QUCKI)/抵抗(HOMA-IR)、空腹血糖和体重指数(BMI)。使用电感耦合等离子体质谱法(ICP-MS)测量必需金属。结果:Fet-A水平高出3倍(1391.4 ± 839.8 ng/ml)高于非T2DM患者(2165.6 ± 651.9对424.3 ± 219.1 ng/ml,p p p p , p p p = 0.049和r = -0.42,p = 0.001)。Se和Zn也与胰岛素抵抗(HOMA-IR)相关(r = -0.45,p = 0.049和r = -0.36,p = 0.012)和胰岛素敏感性(QUIKI)(r = 0.49,p = 0.042和r = 0.30,p = 分别为0.003)。同样,铁与胰岛素水平呈负相关(r = -0.33,p = 0.04)和胰岛素敏感性(r = -0.34,p = 但Mn与Fet-A显著相关(r = 0.37,p = 0.001)和胰岛素抵抗/敏感性(r = 0.24,p = 0.026和r = -0.24,p = 0.041)。镁是糖尿病的独立预测因子。结论:镁通过Fet-a、胰岛素敏感性和耐药性改变在肥胖相关的T2DM发病机制和并发症中发挥重要作用。
{"title":"Impact of essential metals on insulin sensitivity and fetuin in obesity-related type 2 diabetes pathogenesis.","authors":"Anumesh K Pathak, Vandana Tiwari, Manish Raj Kulshrestha, Shivani Singh, Shefali Singh, Vikram Singh","doi":"10.1007/s40200-023-01193-6","DOIUrl":"10.1007/s40200-023-01193-6","url":null,"abstract":"<p><strong>Purpose: </strong>Essential metals may be crucial in obesity and type 2 diabetes (T2DM); diabesity pathogenesis and consequences. This study aimed to determine the metal levels in obese and non-obese patients with and without T2DM and their relationships with fetuin-A(Fet-A) levels, insulin sensitivity, and insulin resistance.</p><p><strong>Methods: </strong>A total of 314 participants were enrolled, with 160 newly diagnosed T2DM patients and 154 non-T2DM subjects categorized into diabetic obese (<i>n</i> = 57), diabetic non-obese (<i>n</i> = 103), non-diabetic obese (<i>n</i> = 48), and non-diabetic non-obese (<i>n</i> = 106) subgroups. Fet-A, insulin sensitivity (QUCKI)/resistance (HOMA-IR), fasting glucose, and body mass index (BMI) were assessed. The essential metals were measured using inductively coupled plasma mass spectroscopy (ICP-MS).</p><p><strong>Results: </strong>Fet-A levels were 3-fold higher (1391.4 ± 839.8 ng/ml) in T2DM patients than in non-T2DM (2165.6 ± 651.9 vs. 424.3 ± 219.1 ng/ml, <i>p</i> < 0.0001). Fet-A levels were 2.3-fold higher in the diabetic obese group than in the diabetic non-obese group (<i>p</i> < 0.0001). Fet-A levels were 2.0-fold higher in the diabetic non-obese group than in the non-diabetic obese group (<i>p</i> < 0.0001). Fet-A levels were positively correlated with insulin resistance (HOMA-IR) (r = 0.34, <i>p</i> < 0.0001) and negatively correlated with insulin sensitivity (QUIKI) (r = -0.41<i>, p</i> < 0.0001).Cu, Se, Zn, and Fe levels were significantly lower in diabetic patients than in non-diabetic patients (<i>p</i> < 0.05). Se and Zn were significantly correlated with Fet-A (r = -0.41, <i>p</i> = 0.049 and r = -0.42, <i>p</i> = 0.001, respectively). Se and Zn were also correlated with insulin resistance (HOMA-IR) (r = -0.45, <i>p</i> = 0.049 and r = -0.36, <i>p</i> = 0.012, respectively) and insulin sensitivity (QUIKI) (r = 0.49, <i>p</i> = 0.042 and r = 0.30, <i>p</i> = 0.003, respectively). Similarly, Fe was negatively correlated with insulin levels (r = -0.33, <i>p</i> = 0.04) and insulin sensitivity (r = -0.34, <i>p</i> = 0.30). However, Mn was significantly correlated with Fet-A (r = 0.37, <i>p</i> = 0.001) and insulin resistance/sensitivity (r = 0.24, <i>p</i> = 0.026 and r = -0.24, <i>p</i> = 0.041) respectively in the diabetic obese group. Mg was an independent predictor of diabesity.</p><p><strong>Conclusions: </strong>Mg play a significant role in obesity-related T2DM pathogenesis and complications via Fet-A, insulin sensitivity, and resistance modifications.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"703-712"},"PeriodicalIF":2.8,"publicationDate":"2023-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9545210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of ABCC8 gene variants with response to sulfonylurea in type 2 diabetes mellitus. ABCC8基因变异与2型糖尿病磺酰脲反应的相关性。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-28 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01189-2
Melika Azimi, Melika Paseban, Sahar Ghareh, Farshad Sharifi, Fatemeh Bandarian, Mandana Hasanzad

Background: Diabetes mellitus (DM) is associated with high blood glucose levels and sulfonylureas (SFUs) are one of the treatment options for DM. SFUs bind to sulfonylurea-1 receptor (SUR1), which is encoded by the ABCC8 gene and leads to blood glucose reduction. Genetic variants like rs757110 and rs1799854 of ABCC8 can influence the response to the drug's efficiency. Therefore, this study aimed to investigate the association between the ABCC8 rs757110 and rs1799854 genetic variants and response to SFUs treatment.

Methods: Totally, 61 DM patients with SFUs treatment were included. Baseline characteristics of the patients were recorded and 5 ml of blood was taken from each patient. After DNA extraction, a sequence containing rs757110 and rs1799854 was synthesized by the PCR method, and the PCR products were used for Sanger sequencing.

Results: Frequencies of GG, GA, and AA genotypes of rs1799854 variant was 12 (40%), 14 (46.7%), and 4 (13.3%), and the frequencies of CC, AC, and AA genotypes for rs757110 variant was 3 (9.7%), 5 (16.1%) and 23 (74.2%) in, respectively. Patients with different genotypes had the same age, BMI (body mass index), initial FBS (Fasting blood sugar), initial HbA1c, treatment duration, gender and history of smoking, alcohol consumption, and exercise. There was no significant difference in FBS and HbA1c changes after SFUs treatment between patients with rs757110 variant (p = 0.39 for FBS and p = 0.76 for HbA1c) and rs1799854 (p = 0.24 for FBS and p = 0.36 for HbA1c).

Conclusion: The rs1799854 and rs757110 variants of the ABCC8 gene had no significant influence on response to SFUs treatment.

背景:糖尿病(DM)与高血糖水平有关,磺酰脲类药物(SFU)是糖尿病的治疗选择之一。SFU与由ABCC8基因编码的磺酰脲-1受体(SUR1)结合,导致血糖降低。ABCC8的rs757110和rs1799854等基因变体可以影响对药物效率的反应。因此,本研究旨在研究ABCC8 rs757110和rs1799854基因变异与SFU治疗反应之间的关系。方法:共纳入61例接受SFU治疗的DM患者。记录患者的基线特征,并从每位患者身上抽取5毫升血液。DNA提取后,用PCR方法合成了含有rs757110和rs1799854的序列,并将PCR产物用于Sanger测序。结果:rs1799854变异株的GG、GA和AA基因型频率分别为12(40%)、14(46.7%)和4(13.3%),rs757110变异株的CC、AC和AA基因频率分别为3(9.7%)、5(16.1%)和23(74.2%)。不同基因型的患者具有相同的年龄、BMI(体重指数)、初始FBS(空腹血糖)、初始HbA1c、治疗持续时间、性别和吸烟史、饮酒史和运动史。rs757110变异体患者SFU治疗后FBS和HbA1c的变化没有显著差异(p = FBS和p为0.39 = HbA1c为0.76)和rs1799854(p = FBS和p为0.24 = 结论:ABCC8基因的rs1799854和rs757110变异对SFU治疗的反应没有显著影响。
{"title":"Association of ABCC8 gene variants with response to sulfonylurea in type 2 diabetes mellitus.","authors":"Melika Azimi, Melika Paseban, Sahar Ghareh, Farshad Sharifi, Fatemeh Bandarian, Mandana Hasanzad","doi":"10.1007/s40200-023-01189-2","DOIUrl":"10.1007/s40200-023-01189-2","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) is associated with high blood glucose levels and sulfonylureas (SFUs) are one of the treatment options for DM. SFUs bind to sulfonylurea-1 receptor (SUR1), which is encoded by the ABCC8 gene and leads to blood glucose reduction. Genetic variants like rs757110 and rs1799854 of <i>ABCC8</i> can influence the response to the drug's efficiency. Therefore, this study aimed to investigate the association between the <i>ABCC8</i> rs757110 and rs1799854 genetic variants and response to SFUs treatment.</p><p><strong>Methods: </strong>Totally, 61 DM patients with SFUs treatment were included. Baseline characteristics of the patients were recorded and 5 ml of blood was taken from each patient. After DNA extraction, a sequence containing rs757110 and rs1799854 was synthesized by the PCR method, and the PCR products were used for Sanger sequencing.</p><p><strong>Results: </strong>Frequencies of GG, GA, and AA genotypes of rs1799854 variant was 12 (40%), 14 (46.7%), and 4 (13.3%), and the frequencies of CC, AC, and AA genotypes for rs757110 variant was 3 (9.7%), 5 (16.1%) and 23 (74.2%) in, respectively. Patients with different genotypes had the same age, BMI (body mass index), initial FBS (Fasting blood sugar), initial HbA1c, treatment duration, gender and history of smoking, alcohol consumption, and exercise. There was no significant difference in FBS and HbA1c changes after SFUs treatment between patients with rs757110 variant (<i>p</i> = 0.39 for FBS and <i>p</i> = 0.76 for HbA1c) and rs1799854 (<i>p</i> = 0.24 for FBS and <i>p</i> = 0.36 for HbA1c).</p><p><strong>Conclusion: </strong>The rs1799854 and rs757110 variants of the ABCC8 gene had no significant influence on response to SFUs treatment.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"649-655"},"PeriodicalIF":2.8,"publicationDate":"2023-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9553238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association of plant-based dietary pattern with general and abdominal obesity: a large cross-sectional study. 植物性饮食模式与全身和腹部肥胖的关系:一项大型横断面研究。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-28 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-022-01166-1
Farzaneh Asoudeh, Seyed Mohammad Mousavi, Ammar Hassanzadeh Keshteli, Shirin Hasani-Ranjbar, Bagher Larijani, Ahmad Esmaillzadeh, Peyman Adibi

Purpose: Only a few studies have studied the association between plant-based dietary index (PDI) and the prevalence of obesity. The purpose of this study was to investigate the association between PDI and the prevalence of general and abdominal obesity in a large sample of Iranian adults.

Methods: The current cross-sectional study was performed from 2010 to 2012 in Isfahan, Iran. This study comprised 6,724 adults between the ages of 18 and 55. We analyzed data from 6,724 participants who were classified as having general obesity and 5,203 individuals who were classified as having abdominal obesity. Dietary intake was assessed using a validated food frequency questionnaire. We determined the PDI by assigning plant foods positive scores and animal foods negative values using the method of Satija et al. General obesity was defined as having a body mass index (BMI) greater than 30 kg/m2, whereas abdominal obesity was classified as having a waist circumference (WC) greater than 88 cm for women and 102 cm for men. Data was examined using Chi-squared test and the analysis of variance (ANOVA and ANCOVA). Multivariable binary logistic regression analyses were performed to evaluate the association between PDI and risk of general as well as abdominal obesity.

Results: The mean age of the study participants was 36.8 ± 8.08 years, and 57% of them were female. General obesity prevalence was 9.6%, while abdominal obesity was 26.8%. In all the unadjusted and multivariable adjusted models of the total population, there was no significant association between highest vs. lowest adherence to the PDI and general obesity or abdominal obesity. No significant association was found when men and women were analyzed separately as well.

Conclusion: In the present study, no association was observed between PDI and general and abdominal obesity in the Iranian adult population.

目的:只有少数研究研究了植物性饮食指数(PDI)与肥胖患病率之间的关系。本研究的目的是在大量伊朗成年人样本中调查PDI与全身和腹部肥胖患病率之间的关系。方法:目前的横断面研究于2010年至2012年在伊朗伊斯法罕进行。这项研究包括6724名年龄在18岁至55岁之间的成年人。我们分析了6724名被归类为一般性肥胖的参与者和5203名被分类为腹部肥胖的参与者的数据。饮食摄入量采用经验证的食物频率问卷进行评估。我们使用Satija等人的方法,通过分配植物性食物的阳性评分和动物性食物的阴性评分来确定PDI。一般肥胖被定义为体重指数(BMI)大于30 kg/m2,而腹部肥胖被分类为女性腰围(WC)大于88 cm,男性腰围大于102 cm。使用卡方检验和方差分析(ANOVA和ANCOVA)对数据进行检验。进行多变量二元逻辑回归分析,以评估PDI与全身和腹部肥胖风险之间的相关性。结果:研究参与者的平均年龄为36.8岁 ± 8.08岁,其中57%为女性。一般性肥胖患病率为9.6%,而腹部肥胖患病率则为26.8%。在所有未经调整和多变量调整的总人口模型中,PDI依从性最高与最低与一般性肥胖或腹部肥胖之间没有显著关联。当分别对男性和女性进行分析时,也没有发现显著的相关性。结论:在本研究中,在伊朗成年人群中,未观察到PDI与全身和腹部肥胖之间的相关性。
{"title":"The association of plant-based dietary pattern with general and abdominal obesity: a large cross-sectional study.","authors":"Farzaneh Asoudeh, Seyed Mohammad Mousavi, Ammar Hassanzadeh Keshteli, Shirin Hasani-Ranjbar, Bagher Larijani, Ahmad Esmaillzadeh, Peyman Adibi","doi":"10.1007/s40200-022-01166-1","DOIUrl":"10.1007/s40200-022-01166-1","url":null,"abstract":"<p><strong>Purpose: </strong>Only a few studies have studied the association between plant-based dietary index (PDI) and the prevalence of obesity. The purpose of this study was to investigate the association between PDI and the prevalence of general and abdominal obesity in a large sample of Iranian adults.</p><p><strong>Methods: </strong>The current cross-sectional study was performed from 2010 to 2012 in Isfahan, Iran. This study comprised 6,724 adults between the ages of 18 and 55. We analyzed data from 6,724 participants who were classified as having general obesity and 5,203 individuals who were classified as having abdominal obesity. Dietary intake was assessed using a validated food frequency questionnaire. We determined the PDI by assigning plant foods positive scores and animal foods negative values using the method of Satija et al. General obesity was defined as having a body mass index (BMI) greater than 30 kg/m<sup>2</sup>, whereas abdominal obesity was classified as having a waist circumference (WC) greater than 88 cm for women and 102 cm for men. Data was examined using Chi-squared test and the analysis of variance (ANOVA and ANCOVA). Multivariable binary logistic regression analyses were performed to evaluate the association between PDI and risk of general as well as abdominal obesity.</p><p><strong>Results: </strong>The mean age of the study participants was 36.8 ± 8.08 years, and 57% of them were female. General obesity prevalence was 9.6%, while abdominal obesity was 26.8%. In all the unadjusted and multivariable adjusted models of the total population, there was no significant association between highest vs. lowest adherence to the PDI and general obesity or abdominal obesity. No significant association was found when men and women were analyzed separately as well.</p><p><strong>Conclusion: </strong>In the present study, no association was observed between PDI and general and abdominal obesity in the Iranian adult population.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"469-477"},"PeriodicalIF":2.8,"publicationDate":"2023-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9606361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. 循环chemerin水平与非酒精性脂肪肝的风险:一项系统综述和荟萃分析。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-28 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01187-4
Mohsen Rastkar, Leila Nikniaz, Mahdieh Abbasalizad Farhangi, Zeinab Nikniaz

Purpose: Chemerin is participating in inflammation procedure and it has role in developing metabolic diseases. In the term of nonalcoholic fatty liver disease (NAFLD), the result of published studies are conflicting. So, in this study, the results of different studies investigating the relationship between chemerin level and NAFLD were summarized.

Method: The databases of PubMed, Scopus, Web of Science, and Embase were systematically searched until October 2022. The inclusion criteria were as follow: measured the mean chemerin level in adults and children with NAFLD and compared it with non-NAFLD population or reported the association between chemerin level and NAFLD. The methodological quality was assessed by the Joanna Briggs Institute (JBI) tool. The meta-analysis was done by STATA software. The pooled results were stated as the standardized mean difference (SMD) and odds ratio (OR) with 95% confidence interval (CI).

Results: Sixteen studies were included in the systematic review, of which 13 studies remained for meta-analysis. The mean serum chemerin level was not significantly different between the groups [SMD: 0.52, 95% CI: -0.35, 1.39]. Moreover, there was no significant correlation between the chemerin level and NAFLD [OR: 1.01, 95% CI: 1, 1.02]. Besides, subgroup analysis indicated a significant correlation between serum chemerin level and NAFLD in children [OR: 1.02, 95% CI: 1.01, 1.03].

Conclusion: There were no significant differences in chemerin levels between the NAFLD and healthy adults; however, the association was significant in children. However, due to the lack of studies in this age group, the conclusion should be made with caution.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01187-4.

目的:Chemerin参与炎症过程,在代谢性疾病的发展中发挥作用。就非酒精性脂肪性肝病(NAFLD)而言,已发表的研究结果相互矛盾。因此,本研究总结了chemerin水平与NAFLD关系的不同研究结果。方法:系统检索PubMed、Scopus、Web of Science和Embase的数据库,直至2022年10月。纳入标准如下:测量成人和儿童NAFLD的平均chemerin水平,并将其与非NAFLD人群进行比较,或报告chemerin含量与NAFLD之间的相关性。方法学质量通过乔安娜·布里格斯研究所(JBI)工具进行评估。荟萃分析采用STATA软件进行。合并结果表示为标准化平均差(SMD)和95%置信区间(CI)的比值比(OR)。结果:16项研究被纳入系统综述,其中13项研究仍有待荟萃分析。两组间血清chemerin平均水平差异无统计学意义[SMD:0.52,95%CI:-0.35,1.39]。此外,chemerin水平与NAFLD无显著相关性[OR:1.01,95%CI:11.02]。此外,亚组分析显示儿童血清chemerin水平与NAFLD之间存在显著相关性[OR:1.02,95%CI:1.01,1.03];然而,这种关联在儿童中是显著的。然而,由于缺乏对这一年龄段的研究,得出结论时应谨慎。补充信息:在线版本包含补充材料,可访问10.1007/s40200-023-01187-4。
{"title":"Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.","authors":"Mohsen Rastkar, Leila Nikniaz, Mahdieh Abbasalizad Farhangi, Zeinab Nikniaz","doi":"10.1007/s40200-023-01187-4","DOIUrl":"10.1007/s40200-023-01187-4","url":null,"abstract":"<p><strong>Purpose: </strong>Chemerin is participating in inflammation procedure and it has role in developing metabolic diseases. In the term of nonalcoholic fatty liver disease (NAFLD), the result of published studies are conflicting. So, in this study, the results of different studies investigating the relationship between chemerin level and NAFLD were summarized.</p><p><strong>Method: </strong>The databases of PubMed, Scopus, Web of Science, and Embase were systematically searched until October 2022. The inclusion criteria were as follow: measured the mean chemerin level in adults and children with NAFLD and compared it with non-NAFLD population or reported the association between chemerin level and NAFLD. The methodological quality was assessed by the Joanna Briggs Institute (JBI) tool. The meta-analysis was done by STATA software. The pooled results were stated as the standardized mean difference (SMD) and odds ratio (OR) with 95% confidence interval (CI).</p><p><strong>Results: </strong>Sixteen studies were included in the systematic review, of which 13 studies remained for meta-analysis. The mean serum chemerin level was not significantly different between the groups [SMD: 0.52, 95% CI: -0.35, 1.39]. Moreover, there was no significant correlation between the chemerin level and NAFLD [OR: 1.01, 95% CI: 1, 1.02]. Besides, subgroup analysis indicated a significant correlation between serum chemerin level and NAFLD in children [OR: 1.02, 95% CI: 1.01, 1.03].</p><p><strong>Conclusion: </strong>There were no significant differences in chemerin levels between the NAFLD and healthy adults; however, the association was significant in children. However, due to the lack of studies in this age group, the conclusion should be made with caution.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40200-023-01187-4.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"83-95"},"PeriodicalIF":2.8,"publicationDate":"2023-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225426/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9545196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Oleanolic acid administration on hepatic AMPK, SIRT-1, IL-6 and NF-κB levels in experimental diabetes. 齐墩果酸对实验性糖尿病患者肝脏AMPK、SIRT-1、IL-6和NF-κB水平的影响。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-28 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-022-01178-x
Hatice Iskender, Eda Dokumacioglu, Kubra Asena Terim Kapakin, Ismail Bolat, Behzat Mokhtare, Armagan Hayirli, Guler Yenice

Objectives: Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) / Sirtuin-1 (SIRT-1) activator and Interleukin 6 (IL-6) / Nuclear factor kappa B (NF-κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.

Methods: Twenty-eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.

Results: The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT-1 (47%) levels and higher hepatic NF-κB (53%) and IL-6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT-1 level, but tended to increase hepatic AMPK level and decrease hepatic NF-κB and IL-6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.

Conclusion: The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects.

目的:糖尿病(DM)是世界范围内一个重要的公共卫生问题,其并发症和患病率不断上升。齐墩果酸(OA)通过调节葡萄糖代谢,发挥5'-腺苷一磷酸(AMP)激活蛋白激酶(AMPK)/SIRT-1激活剂和白细胞介素-6(IL-6)/核因子κB(NF-κB)抑制剂的作用,具有抗糖尿病作用。这项研究质疑OA治疗是否会恶化糖尿病大鼠的肝脏炎症特征。方法:首先对28只雄性Sprague-Dawley大鼠进行无糖尿病诱导(健康)或通过腹膜内注射50mg/kg链脲佐菌素诱导糖尿病。然后,两组大鼠用自来水或OA(5mg/kg)经口灌胃在1ml自来水内处理21天。结果:糖尿病大鼠肝脏MDA(2.88x)、血清AST(2.01x)、ALP(2.22x)和ALT(4.27x)水平高于健康大鼠,肝脏SOD水平低于健康大鼠50%。OA治疗显著逆转了糖尿病大鼠的这些抗氧化参数。与健康大鼠相比,糖尿病大鼠的AMPK(85%)和肝脏SIRT-1(47%)水平较低,肝脏NF-κB(53%)和IL-6(34%)水平较高。与健康大鼠相比,OA治疗增加了糖尿病大鼠肝脏SIRT-1水平,但倾向于增加肝脏AMPK水平,降低肝脏NF-κB和IL-6水平。它还部分有效地改善糖尿病大鼠的退行性变化和坏死。结论:OA治疗可减轻糖尿病患者肝细胞氧化应激,减轻炎症程度。
{"title":"Effect of Oleanolic acid administration on hepatic AMPK, SIRT-1, IL-6 and NF-κB levels in experimental diabetes.","authors":"Hatice Iskender, Eda Dokumacioglu, Kubra Asena Terim Kapakin, Ismail Bolat, Behzat Mokhtare, Armagan Hayirli, Guler Yenice","doi":"10.1007/s40200-022-01178-x","DOIUrl":"10.1007/s40200-022-01178-x","url":null,"abstract":"<p><strong>Objectives: </strong>Diabetes mellitus (DM) is an important public health problem all over the world, considering its complications and increasing prevalence. Oleanolic acid (OA) has anti-diabetic property via modulating glucose metabolism and acting as 5'-adenosine monophosphate (AMP)-activated protein kinase (AMPK) / Sirtuin-1 (SIRT-1) activator and Interleukin 6 (IL-6) / Nuclear factor kappa B (NF-κB) inhibitor. This research questioned if the OA treatment amliorates the hepatic inflammatory profile in the diabetic rats.</p><p><strong>Methods: </strong>Twenty-eight male Sprague Dawley rats were first subjected to either no diabetes induction (healthy) or diabetes induction by i.p. injection of 50 mg/kg streptozotocin. Then rats in both groups were treated with either tap water or OA (5 mg/kg) within 1 ml tap water by oral gavage for 21 days.</p><p><strong>Results: </strong>The diabetic rats had higher hepatic MDA (2.88x) and serum AST (2.01x), ALP (2.22x), and ALT (4.27x) levels and 50% lower hepatic SOD level than the healthy rats. The OA treatment significantly reversed these antioxidant parameters in the diabetic rats. The diabetic rats had lower AMPK (85%) and hepatic SIRT-1 (47%) levels and higher hepatic NF-κB (53%) and IL-6 (34%) levels than the healthy rats. Comparing with the health rats, the OA treatment increased hepatic SIRT-1 level, but tended to increase hepatic AMPK level and decrease hepatic NF-κB and IL-6 levels in the diabetic rats. It was also partially effective to ameliorate degenerative changes and necrosis in the diabetic rats.</p><p><strong>Conclusion: </strong>The OA treatment can be considered to alleviate oxidative stress and reduce severity of inflammation in hepatocytes in the diabetic subjects.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"581-590"},"PeriodicalIF":2.8,"publicationDate":"2023-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225422/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9606363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The risk of experiencing depression among older adults in India: A cross-sectional study. 印度老年人患抑郁症的风险:一项横断面研究。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-19 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01185-6
Subhojit Shaw, Junaid Khan

Background: The comorbidity of diabetes and depression poses a major challenge to older adults. While a few small scale studies have investigated the diabetes associated risk of experiencing depression, there is no national-level study available for India on the same. In this context, this study estimates the burden and risk of depression due to diabetes among older adults aged 45 and above in India while adjusting for socio-economic and demographic characteristics of the individuals.

Methods: Longitudinal Ageing Study in India (LASI), 2017-2018 wave 1 data was utilised in this study. The prevalence of depression and diabetes were estimated by background characteristics using bivariate cross-tabulation. In addition, multivariate logistic regression was applied to examine the likelihood of depression associated with diabetes and other covariates.

Result: Empirical estimation demonstrated that 14% of males and 8% of females with diabetes suffer from depression in the 45-59 age group. A diabetic person aged 45 and above was 16% more likely to suffer from depression than a non-diabetic person; whereas, a diabetic elderly aged 60 and above was 24% more likely to experience depression than their non-diabetic counterparts. The multivariate analysis confirmed a highly statistically significant association between diabetes and depression indicating a substantial risk to experience depression among those older adults and elderly who suffer from diabetes.

Conclusion: Elderly population (60 +) is at higher risk of experiencing depression due to diabetes. Therefore, public health care awareness should be raised, particularly among endocrinologists or specialist doctors who provide treatment at the tertiary-care hospitals in India. The health care experts should refer/recommend the diabetic patients to screen for depressive symptoms.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01185-6.

背景:糖尿病和抑郁症的合并症对老年人构成了重大挑战。虽然一些小规模的研究已经调查了糖尿病相关的抑郁症风险,但印度还没有国家层面的研究。在这种情况下,这项研究估计了印度45岁及以上老年人因糖尿病而患抑郁症的负担和风险,同时根据个人的社会经济和人口特征进行了调整。方法:本研究采用印度纵向老龄化研究(LASI)2017-2018年第1波数据。抑郁症和糖尿病的患病率是通过使用双变量交叉表的背景特征来估计的。此外,应用多变量逻辑回归来检查与糖尿病和其他协变量相关的抑郁症的可能性。结果:经验估计表明,在45-59岁年龄组中,14%的男性和8%的女性糖尿病患者患有抑郁症。45岁及以上的糖尿病患者患抑郁症的可能性比非糖尿病患者高16%;而60岁及以上患有糖尿病的老年人患抑郁症的可能性比非糖尿病老年人高24%。多变量分析证实了糖尿病和抑郁症之间具有高度统计学意义的相关性,这表明老年人和患有糖尿病的老年人患抑郁症的风险很大。结论:老年人口(60 +) 因糖尿病而患抑郁症的风险更高。因此,应该提高公共卫生保健意识,特别是在印度三级护理医院提供治疗的内分泌学家或专科医生中。健康护理专家应推荐糖尿病患者进行抑郁症状筛查。补充信息:在线版本包含补充材料,请访问10.1007/s40200-023-01185-6。
{"title":"The risk of experiencing depression among older adults in India: A cross-sectional study.","authors":"Subhojit Shaw,&nbsp;Junaid Khan","doi":"10.1007/s40200-023-01185-6","DOIUrl":"10.1007/s40200-023-01185-6","url":null,"abstract":"<p><strong>Background: </strong>The comorbidity of diabetes and depression poses a major challenge to older adults. While a few small scale studies have investigated the diabetes associated risk of experiencing depression, there is no national-level study available for India on the same. In this context, this study estimates the burden and risk of depression due to diabetes among older adults aged 45 and above in India while adjusting for socio-economic and demographic characteristics of the individuals.</p><p><strong>Methods: </strong>Longitudinal Ageing Study in India (LASI), 2017-2018 wave 1 data was utilised in this study. The prevalence of depression and diabetes were estimated by background characteristics using bivariate cross-tabulation. In addition, multivariate logistic regression was applied to examine the likelihood of depression associated with diabetes and other covariates.</p><p><strong>Result: </strong>Empirical estimation demonstrated that 14% of males and 8% of females with diabetes suffer from depression in the 45-59 age group. A diabetic person aged 45 and above was 16% more likely to suffer from depression than a non-diabetic person; whereas, a diabetic elderly aged 60 and above was 24% more likely to experience depression than their non-diabetic counterparts. The multivariate analysis confirmed a highly statistically significant association between diabetes and depression indicating a substantial risk to experience depression among those older adults and elderly who suffer from diabetes.</p><p><strong>Conclusion: </strong>Elderly population (60 +) is at higher risk of experiencing depression due to diabetes. Therefore, public health care awareness should be raised, particularly among endocrinologists or specialist doctors who provide treatment at the tertiary-care hospitals in India. The health care experts should refer/recommend the diabetic patients to screen for depressive symptoms.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40200-023-01185-6.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"629-638"},"PeriodicalIF":2.8,"publicationDate":"2023-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9924288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Melatonin improves liver and pancreatic tissue injuries in diabetic rats: role on antioxidant enzymes. 褪黑素改善糖尿病大鼠肝脏和胰腺组织损伤:对抗氧化酶的作用。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-13 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-022-01179-w
Onur Ertik, Bertan Boran Bayrak, Goksel Sener, Refiye Yanardag

Purpose: Melatonin (Mel) is an indolamine mainly synthesized by the pineal gland and many other organs. It plays an important role in scavenging free radicals and stimulating antioxidant enzymes. The goal of this study was to investigate the effect of Mel and/or insulin treatment on oxidative liver and pancreas injuries in diabetic rats.

Methods: Male Wistar albino rats were assigned into 5 groups. Group I: control animals. Group II: diabetes was induced via a single dose of STZ (60 mg/kg) administered intraperitoneally. Group III: diabetic rats treated with Mel (10 mg/kg/day). Group IV: diabetic rats given insulin (6U/kg) subcutaneously. Group V: diabetic rats that received insulin and Mel at the same dose and time. After 12 weeks of the experiment, the animals were decapitated, liver and pancreas tissues were collected.

Results: The results indicated that reduced glutathione levels in liver and pancreatic tissue decreased, while protein carbonyl, advanced oxidized protein products and lipid peroxidation levels were elevated in diabetic group. Antioxidant enzyme activities decreased in liver tissues but increased in pancreatic tissues of the diabetic group. Administration of Mel, insulin or Mel + insulin reversed these biochemical changes in the diabetic animals.

Conclusion: This work shows that in long-term oxidative stress conditions caused by STZ-induced diabetes, either Mel or Mel + insulin administration may improve the deteriorated oxidant/antioxidant system in both the liver and pancreas tissues. These results suggested that Mel alone or Mel + insulin treatments might have a significant role in protecting against liver and pancreatic damage in STZ diabetic rats via different antioxidant effects.

目的:褪黑激素(Mel)是一种主要由松果体和许多其他器官合成的吲哚胺。它在清除自由基和刺激抗氧化酶方面起着重要作用。本研究的目的是研究Mel和/或胰岛素治疗对糖尿病大鼠氧化性肝和胰腺损伤的影响。方法:雄性Wistar白化大鼠随机分为5组。第一组:对照动物。第II组:通过腹膜内给予单剂量STZ(60mg/kg)诱导糖尿病。第III组:用Mel(10mg/kg/天)治疗糖尿病大鼠。IV组:糖尿病大鼠皮下注射胰岛素6U/kg。第五组:糖尿病大鼠接受相同剂量和时间的胰岛素和梅尔。实验12周后,将动物斩首,收集肝脏和胰腺组织。结果:糖尿病组肝和胰腺组织中还原型谷胱甘肽水平下降,而蛋白羰基、晚期氧化蛋白产物和脂质过氧化水平升高。抗氧化酶活性在糖尿病组的肝组织中降低,但在胰腺组织中增加。Mel、胰岛素或Mel的给药 + 胰岛素逆转了糖尿病动物的这些生化变化。结论:这项工作表明,在STZ诱导的糖尿病引起的长期氧化应激条件下,Mel或Mel + 胰岛素给药可以改善肝脏和胰腺组织中恶化的氧化剂/抗氧化系统。这些结果表明梅尔单独或梅尔 + 胰岛素治疗可能通过不同的抗氧化作用在保护STZ糖尿病大鼠免受肝脏和胰腺损伤方面发挥重要作用。
{"title":"Melatonin improves liver and pancreatic tissue injuries in diabetic rats: role on antioxidant enzymes.","authors":"Onur Ertik, Bertan Boran Bayrak, Goksel Sener, Refiye Yanardag","doi":"10.1007/s40200-022-01179-w","DOIUrl":"10.1007/s40200-022-01179-w","url":null,"abstract":"<p><strong>Purpose: </strong>Melatonin (Mel) is an indolamine mainly synthesized by the pineal gland and many other organs. It plays an important role in scavenging free radicals and stimulating antioxidant enzymes. The goal of this study was to investigate the effect of Mel and/or insulin treatment on oxidative liver and pancreas injuries in diabetic rats.</p><p><strong>Methods: </strong>Male Wistar albino rats were assigned into 5 groups. Group I: control animals. Group II: diabetes was induced via a single dose of STZ (60 mg/kg) administered intraperitoneally. Group III: diabetic rats treated with Mel (10 mg/kg/day). Group IV: diabetic rats given insulin (6U/kg) subcutaneously. Group V: diabetic rats that received insulin and Mel at the same dose and time. After 12 weeks of the experiment, the animals were decapitated, liver and pancreas tissues were collected.</p><p><strong>Results: </strong>The results indicated that reduced glutathione levels in liver and pancreatic tissue decreased, while protein carbonyl, advanced oxidized protein products and lipid peroxidation levels were elevated in diabetic group. Antioxidant enzyme activities decreased in liver tissues but increased in pancreatic tissues of the diabetic group. Administration of Mel, insulin or Mel + insulin reversed these biochemical changes in the diabetic animals.</p><p><strong>Conclusion: </strong>This work shows that in long-term oxidative stress conditions caused by STZ-induced diabetes, either Mel or Mel + insulin administration may improve the deteriorated oxidant/antioxidant system in both the liver and pancreas tissues. These results suggested that Mel alone or Mel + insulin treatments might have a significant role in protecting against liver and pancreatic damage in STZ diabetic rats via different antioxidant effects.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"591-602"},"PeriodicalIF":2.8,"publicationDate":"2023-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9551407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health literacy and self-efficacy of the elderly with diabetes. 糖尿病老年人的健康素养和自我效能感。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-13 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01181-w
Abdollah Goli Roshan, Seyedeh Navabeh Hosseinkhani, Reza Norouzadeh

Aim: This study aimed to investigate the relationship between health literacy and self-efficacy in the elderly with diabetes.

Method: This cross-sectional study was conducted on 375 diabetic elderly members from a diabetes association, in Iran. Self-efficacy and health literacy questionnaires were used. The Pearson test was used to determine the relationship between self-efficacy and health literacy and linear regression was used to predict self-efficacy by health literacy.

Results: Elderly men and women with diabetes showed a significant difference in terms of health literacy (P = 0.003). People over the age of 70 had a lower level of literacy (P < 0.05). The highest and lowest self-efficacy in the elderly patients were related to taking medications (89.75 ± 17.56) and physical activity (71.38 ± 24.40), respectively. The results of stepwise linear regression showed that health literacy is a predictor of self-efficacy in the diabetic elderly (r2 = 0.55, P < 0.001).

Conclusion: Health literacy is directly related to self-efficacy in older people with diabetes.

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01181-w.

目的:探讨糖尿病老年人健康素养与自我效能感的关系。方法:这项横断面研究对375名来自伊朗糖尿病协会的糖尿病老年成员进行。使用了自我效能感和健康素养问卷。Pearson检验用于确定自我效能感与健康素养之间的关系,线性回归用于通过健康素养预测自我效能感。结果:老年糖尿病男性和女性在健康素养方面存在显著差异(P = 0.003)。70岁以上人群的识字水平较低(P 2. = 0.55,P 结论:老年糖尿病患者的健康素养与自我效能感直接相关。补充信息:在线版本包含补充材料,网址为10.1007/s40200-023-01181-w。
{"title":"Health literacy and self-efficacy of the elderly with diabetes.","authors":"Abdollah Goli Roshan, Seyedeh Navabeh Hosseinkhani, Reza Norouzadeh","doi":"10.1007/s40200-023-01181-w","DOIUrl":"10.1007/s40200-023-01181-w","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to investigate the relationship between health literacy and self-efficacy in the elderly with diabetes.</p><p><strong>Method: </strong>This cross-sectional study was conducted on 375 diabetic elderly members from a diabetes association, in Iran. Self-efficacy and health literacy questionnaires were used. The Pearson test was used to determine the relationship between self-efficacy and health literacy and linear regression was used to predict self-efficacy by health literacy.</p><p><strong>Results: </strong>Elderly men and women with diabetes showed a significant difference in terms of health literacy (P = 0.003). People over the age of 70 had a lower level of literacy (P < 0.05). The highest and lowest self-efficacy in the elderly patients were related to taking medications (89.75 ± 17.56) and physical activity (71.38 ± 24.40), respectively. The results of stepwise linear regression showed that health literacy is a predictor of self-efficacy in the diabetic elderly (r<sup>2</sup> = 0.55, P < 0.001).</p><p><strong>Conclusion: </strong>Health literacy is directly related to self-efficacy in older people with diabetes.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40200-023-01181-w.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"611-617"},"PeriodicalIF":2.8,"publicationDate":"2023-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9553579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of smartphone-based physical activity intervention on executive functions and cardiometabolic disease risk in obese young adults: a pilot randomised controlled trial. 基于智能手机的体育活动干预对肥胖年轻人执行功能和心脏代谢疾病风险的影响:一项试点随机对照试验。
IF 2.8 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-13 eCollection Date: 2023-06-01 DOI: 10.1007/s40200-023-01182-9
Sapna Vithoba Domal, Baskaran Chandrasekaran, Hari Prakash Palanisamy

Purpose: Smartphone is an impending solution to influence long-term behavior change, including physical activity; however, the evidence regarding personalized prescription remains mixed in obese. We aimed to explore the influence of smartphone-based physical activity promotion on weight loss and cognitive functions in obese young adults.

Methods: In our pilot randomised controlled trial, 24 obese adults were randomized to two conditions: (1) EXI group receiving a smartphone-application based personalized physical activity prescription; (2) CONT group continuing their routine work for eight weeks. Executive functions and cardiometabolic risk variables [body and fat mass, waist circumference (WC), blood pressure (BP)] and executive functions were measured before and after eight weeks.

Results: Our study findings revealed a significant improvement in reaction times with overall (H = 7.71, p = 0.005), congruent stimuli (H = 4.43, p = 0.03) and incongruent stimuli (H = 5.35, p = 0.02) between groups. Though EXI participants reduced their fat mass by 5.07 kg more than CONT group users after eight weeks, the findings were statistically insignificant. Similarly, our study did not find significant differences in body mass, WC, BP or accuracy between EXI and CONT groups. There was a decreased user engagement (H = 5.80, p = 0.564) after the 3rd week of the study period.

Conclusion: Short-term smartphone-based physical activity programs may offer favourable cognitive benefits to young adults; however, the weight loss benefits remain unconvincing.

Trial registration: The study was registered prospectively with the Clinical Trials Registry of India (CTRI/2022/02/040202).

Supplementary information: The online version contains supplementary material available at 10.1007/s40200-023-01182-9.

目的:智能手机是影响长期行为改变的一种即将到来的解决方案,包括体育活动;然而,关于个性化处方的证据仍然混杂在肥胖人群中。我们旨在探讨基于智能手机的体育活动促进对肥胖年轻人减肥和认知功能的影响。方法:在我们的试点随机对照试验中,24名肥胖成年人被随机分为两种情况:(1)EXI组接受基于智能手机应用程序的个性化体育活动处方;(2) CONT小组继续他们的日常工作八周。在八周前和八周后测量执行功能和心脏代谢风险变量[体重和脂肪量、腰围(WC)、血压(BP)]以及执行功能。结果:我们的研究结果显示,总体(H = 7.71,p = 0.005),一致刺激(H = 4.43,p = 0.03)和不协调刺激(H = 5.35,p = 0.02)。尽管EXI参与者在八周后比CONT组用户多减少了5.07公斤的脂肪量,但这一发现在统计学上并不重要。同样,我们的研究没有发现EXI组和CONT组在体重、WC、BP或准确性方面存在显著差异。用户参与度下降(H = 5.80,p = 0.564)。结论:基于智能手机的短期体育活动项目可能为年轻人提供有利的认知益处;然而,减肥的好处仍然不能令人信服。试验注册:该研究在印度临床试验注册中心进行了前瞻性注册(CTRI/2022/02/040202)。补充信息:在线版本包含补充材料,可访问10.1007/s40200-023-01182-9。
{"title":"Influence of smartphone-based physical activity intervention on executive functions and cardiometabolic disease risk in obese young adults: a pilot randomised controlled trial.","authors":"Sapna Vithoba Domal,&nbsp;Baskaran Chandrasekaran,&nbsp;Hari Prakash Palanisamy","doi":"10.1007/s40200-023-01182-9","DOIUrl":"10.1007/s40200-023-01182-9","url":null,"abstract":"<p><strong>Purpose: </strong>Smartphone is an impending solution to influence long-term behavior change, including physical activity; however, the evidence regarding personalized prescription remains mixed in obese. We aimed to explore the influence of smartphone-based physical activity promotion on weight loss and cognitive functions in obese young adults.</p><p><strong>Methods: </strong>In our pilot randomised controlled trial, 24 obese adults were randomized to two conditions: (1) EXI group receiving a smartphone-application based personalized physical activity prescription; (2) CONT group continuing their routine work for eight weeks. Executive functions and cardiometabolic risk variables [body and fat mass, waist circumference (WC), blood pressure (BP)] and executive functions were measured before and after eight weeks.</p><p><strong>Results: </strong>Our study findings revealed a significant improvement in reaction times with overall (H = 7.71, p = 0.005), congruent stimuli (H = 4.43, p = 0.03) and incongruent stimuli (H = 5.35, p = 0.02) between groups. Though EXI participants reduced their fat mass by 5.07 kg more than CONT group users after eight weeks, the findings were statistically insignificant. Similarly, our study did not find significant differences in body mass, WC, BP or accuracy between EXI and CONT groups. There was a decreased user engagement (H = 5.80, p = 0.564) after the 3rd week of the study period.</p><p><strong>Conclusion: </strong>Short-term smartphone-based physical activity programs may offer favourable cognitive benefits to young adults; however, the weight loss benefits remain unconvincing.</p><p><strong>Trial registration: </strong>The study was registered prospectively with the Clinical Trials Registry of India (CTRI/2022/02/040202).</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s40200-023-01182-9.</p>","PeriodicalId":15635,"journal":{"name":"Journal of Diabetes and Metabolic Disorders","volume":"22 1","pages":"619-628"},"PeriodicalIF":2.8,"publicationDate":"2023-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9556830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Diabetes and Metabolic Disorders
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1